INMUNOENSAYO ENZIMÁTICO PARA LA MEDICIÓN CUANTITATIVA DE INTERLEUCINA 1BETA HUMANA (IL-1BETA) EN SUERO O PLASMA
Mexico·Clase II·III. Agentes de
diagnóstico·INOCHEM, S.A. DE C.V.·Registered July 01, 2024- Risk Class / Clase de Riesgo
- Clase II
- Product Type (Spanish)
- III. Agentes de diagnóstico
- Product Type (English)
- III. Agentes de diagnóstico
- Trade Name (Spanish)
- INTERLEUKIN-1BETA HUMAN ELISA.
- Trade Name (English)
- INTERLEUKIN-1BETA HUMAN ELISA.
- Analysis ID
- 1846R2024 SSA
- Registration Date
- July 01, 2024
- Name (Spanish)
- INOCHEM, S.A. DE C.V.
- Name (English)
- INOCHEM, S.A. DE C.V.
Access comprehensive regulatory information for INMUNOENSAYO ENZIMÁTICO PARA LA MEDICIÓN CUANTITATIVA DE INTERLEUCINA 1BETA HUMANA (IL-1BETA) EN SUERO O PLASMA (INMUNOENSAYO ENZIMÁTICO PARA LA MEDICIÓN CUANTITATIVA DE INTERLEUCINA 1BETA HUMANA (IL-1BETA) EN SUERO O PLASMA) in the Mexico medical device market through Pure Global AI's free database. This Clase II medical device is registered under COFEPRIS analysis ID 1846R2024 SSA and manufactured by INOCHEM, S.A. DE C.V.. The device was registered on July 01, 2024.
This page provides complete registration details including product type (III. Agentes de diagnóstico), manufacturer information, and regulatory compliance data from the official Mexico COFEPRIS medical device database. Pure Global AI offers free access to Mexico's complete medical device registry with bilingual Spanish/English support, helping global MedTech companies navigate COFEPRIS regulations efficiently.